[VERT(Vertebral Efficacy with Risedronate Therapy)-MN(Multinational) Study and VERT-NA(North America) Study].
Fukunaga
Masao
M
Department of Nuclear Medicine, Kawasaki Medical School.
D000368:Aged; D015519:Bone Density; D012968:Etidronic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D010024:Osteoporosis / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology; D016032:Randomized Controlled Trials as Topic; D000068296:Risedronic Acid; D012306:Risk; D016103:Spinal Fractures / Q000209:etiology / Q000517:prevention & control*
D000068296:Risedronic Acid; D012968:Etidronic Acid